Literature DB >> 7441205

Ebola virus: identification of virion structural proteins.

M P Kiley, R L Regnery, K M Johnson.   

Abstract

Polyacrylamide gel electrophoresis of purified Ebola virus revealed the presence of four major virion structural proteins which we have designated VP1, VP2, VP3 and VP4. Vesicular stomatitis virus (VSV) proteins were used as mol. wt. markers, and the virion proteins were found to have mol. wt. of 125000 (VP1), 104000 (VP2), 40000 (VP3) and 26000 (VP4). VP1 was labelled with glucosamine and is probably a glycoprotein. The density of the Ebola virion was approx. 1.14g/ml in potassium tartrate. Virus nucleocapsids with a density of 1.32g/ml in caesium chloride were released when virions were treated with detergents. Proteins VP2 and VP3 were consistently associated with released nucleocapsids and are probably the major structural nucleocapsid proteins analogous to the N protein of VSV. Protein VP4 was reduced or absent in released nucleocapsids and is probably analogous to the membrane (M) protein of VSV and similar viruses. The glycoprotein (VP1) is larger than the glycoprotein of any known negative-strand RNA virus and is not labelled well with 35S-methionine. VP1 is solubilized by detergent treatment, suggesting that it is a component of the virion spikes and analogous to the G protein of VSV. Our results, in conjunction with analysis of Ebola virion RNA (Regnery et al. 1980), strongly suggest that the virus is a negative-strand RNA virus and, along with marburg virus, may constitute a new taxon within this group.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7441205     DOI: 10.1099/0022-1317-49-2-333

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  Development of an immunofluorescence focus assay for Ebola virus.

Authors:  A L Truant; R L Regnery; M P Kiley
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

2.  Plaque assay for Ebola virus.

Authors:  J B Moe; R D Lambert; H W Lupton
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

3.  A system for functional analysis of Ebola virus glycoprotein.

Authors:  A Takada; C Robison; H Goto; A Sanchez; K G Murti; M A Whitt; Y Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

Review 4.  Ebola Virus Disease and Current Therapeutic Strategies: A Review.

Authors:  Kalliopi Io Diakou; Thanasis Mitsis; Katerina Pierouli; Eleni Papakonstantinou; Erik Bongcam-Rudloff; Misaki Wayengera; Dimitrios Vlachakis
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Ebola protein analyses for the determination of genetic organization.

Authors:  L H Elliott; A Sanchez; B P Holloway; M P Kiley; J B McCormick
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

6.  Biochemical analysis of the secreted and virion glycoproteins of Ebola virus.

Authors:  A Sanchez; Z Y Yang; L Xu; G J Nabel; T Crews; C J Peters
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

7.  Successful topical respiratory tract immunization of primates against Ebola virus.

Authors:  Alexander Bukreyev; Pierre E Rollin; Mallory K Tate; Lijuan Yang; Sherif R Zaki; Wun-Ju Shieh; Brian R Murphy; Peter L Collins; Anthony Sanchez
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

8.  Analysis of linear B-cell epitopes of the nucleoprotein of ebola virus that distinguish ebola virus subtypes.

Authors:  Masahiro Niikura; Tetsuro Ikegami; Masayuki Saijo; Takeshi Kurata; Ichiro Kurane; Shigeru Morikawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

Review 9.  Standardization of the filovirus plaque assay for use in preclinical studies.

Authors:  Amy C Shurtleff; Julia E Biggins; Ashley E Keeney; Elizabeth E Zumbrun; Holly A Bloomfield; Ana Kuehne; Jennifer L Audet; Kendra J Alfson; Anthony Griffiths; Gene G Olinger; Sina Bavari
Journal:  Viruses       Date:  2012-12-06       Impact factor: 5.048

10.  Contamination during doffing of personal protective equipment by healthcare providers.

Authors:  Seong Mi Lim; Won Chul Cha; Minjung Kathy Chae; Ik Joon Jo
Journal:  Clin Exp Emerg Med       Date:  2015-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.